JONATHAN COUCHMAN
CIK 1265094 · President and CEO · last filed 2025-08-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
13
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENZO BIOCHEM INC (ENZ) Delisted | Director | 272,897 | $0.31 | $85.6K | $0 | 1 | 2025-01-17 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (GTA) Delisted | Director | — | — | — | $0 | 2 | 2010-01-20 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-04-01 | — | Grant (A) | +20,000 | $90.0K | |
| 2007-07-20 | — | Grant (A) | +20,965 | $0 | |
| 2007-04-03 | — | Grant (A) | +10,676 | $90.0K |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.